GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Alexza Pharmaceuticals, Inc. (ALXA) [hlAlert]

Rating:
Strong Buy
ALXA
down 95.31 %

Alexza Pharmaceuticals, Inc. (ALXA) rated Strong Buy with price target $6 by WBB Securities

Posted on: Thursday,  Feb 11, 2010  10:25 AM ET by WBB Securities

WBB Securities rated Strong Buy Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) on 02/11/2010. Previously WBB Securities rated Buy Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA)
on 01/28/2010., when the stock price was $25.20. Since then, Alexza Pharmaceuticals, Inc. has lost 95.32% as of 08/27/2015's recent price of $1.18.
If you would have followed the previous WBB Securities's recommendation on ALXA, you would have lost 95.31% of your investment in 2037 days.

Alexza Pharmaceuticals is an emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience.

Research from WBB Securities provides investment professionals with up-to-date, in-depth, accurate and insightful reporting of companies that specialize in biotechnology, medical devices and healthcare. Our goal is to provide independent, straight-forward and up-to-date research so you can make educated decisions about your investments.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/11/2010 10:25 AM Buy
None
27.20 60.00
as of 12/31/2010
1 Week up  6.50 %
1 Month up  45.55 %
3 Months down  -58.67 %
1 YTD down  -51.83 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/28/2010 5:25 PM Buy
None
25.20 40.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy